Delivery Order SPE2DB20D1100-SPE2DB25FE6S3
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,375.92 for the Menveo vaccine (5-dose vial) by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $45K on July 23, 2025, for the supply of Menveo vaccine (5-dose vials). This competitively awarded, firm fixed-price delivery order is expected to be completed by July 24, 2025, and will be performed at the contractor's Conshohocken facility. The award was funded by the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,616.96 firm fixed-price delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). The contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $262,572.45 delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products. The contract, with a completion date of July 23, 2025, represents a competitive, non-set-aside award utilizing firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- AmerisourceBergen Drug Corp was awarded a $38,694 delivery order by the Defense Logistics Agency (DLA) on June 12, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This competitively awarded, firm fixed price contract carries no set-aside designation and has an ultimate completion date of June 13, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,059.20 on August 29, 2025, for supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency Medical Supply Chain, a defense agency component, with an ultimate completion date of September 2, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine, with a ceiling value of $6,449.00. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- This delivery order, issued by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp $1,260.84 for the supply of Menveo vaccine (1 vial, formulation A-C-Y-W-135-DIP, 0.5ml) with completion targeted for June 30, 2025. The award utilizes firm fixed pricing under a non-set-aside, competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,620.28 by the Defense Logistics Agency's Medical Supply Chain for the delivery of MENVEO VACCINE VL 5S, a meningococcal vaccine product. The contract, awarded on September 12, 2025, utilizes firm fixed pricing with an ultimate completion date of October 9, 2025. This is a competitive award with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $330,482.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This is a non-set-aside competitive award with an ultimate completion date of August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6S3Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $25,338.10 firm fixed-price delivery order from the Defense Logistics Agency on September 15, 2025, for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccines. This is a non-set-aside competitive award with an ultimate completion date of September 16, 2025, and performance will occur at the company's Conshohocken, PA facility. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. As a critical vendor in the federal medical procurement landscape, the company demonstrates consistent capability to meet Defense Logistics Agency requirements through open competition. The DLA Troop Support Medical contract represents the company's primary vehicle for fulfilling federal vaccine and pharmaceutical needs across the military healthcare system and supporting agencies including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.3k | 9/15/25 |